Jason Coloma

Jason Coloma is a Board Member at Alloy Therapeutics. Jason has held this position since August 2018. Prior to this, they were the Interim Chief Business Officer at insitro from August 2019 to August 2019. From July 2017 to November 2018, they were the Interim Chief Business Officer at Celsius Therapeutics. Jason Coloma has also been a Venture Partner at Third Rock Ventures from June 2017 to June 2019, and the SVP, Chief Business Officer at Corvus Pharmaceuticals from July 2016 to July 2017. Jason was also a Board Member at Tidal Therapeutics from May 2019 to April 2021. Prior to their work in the biotech industry, Jason Coloma worked in Roche / Genentech from January 2008 to June 2016, where they held the title of Vice President.

Jason Coloma has an MBA from the Tuck School of Business at Dartmouth and degrees from the University of California, Berkeley and the University of San Francisco.